These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 26819445)

  • 1. Patient assessment of diabetes care in a pay-for-performance program.
    Chiu HC; Hsieh HM; Lin YC; Kuo SJ; Kao HY; Yeh SC; Chang WH; Hsiao PJ; Chen YS; Lin SL; Lo GH; Ker CG; Hung YH; Cheng HA; Chou TH; Chou SY; Wang JH; Wang CF
    Int J Qual Health Care; 2016 Apr; 28(2):183-90. PubMed ID: 26819445
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differences in patient reports on the quality of care in a diabetes pay-for-performance program between 1 year enrolled and newly enrolled patients.
    Chen PC; Lee YC; Kuo RN
    Int J Qual Health Care; 2012 Apr; 24(2):189-96. PubMed ID: 22350921
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of the pay-for-performance program for breast cancer care in Taiwan.
    Kuo RN; Chung KP; Lai MS
    Am J Manag Care; 2011 May; 17(5 Spec No):e203-11. PubMed ID: 21711072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Does pay-for-performance benefit patients with multiple chronic conditions? Evidence from a universal coverage health care system.
    Chen CC; Cheng SH
    Health Policy Plan; 2016 Feb; 31(1):83-90. PubMed ID: 25944704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of a PPO pay-for-performance program on patients with diabetes.
    Chen JY; Tian H; Taira Juarez D; Hodges KA; Brand JC; Chung RS; Legorreta AP
    Am J Manag Care; 2010 Jan; 16(1):e11-9. PubMed ID: 20059287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implementing elements of a context-adapted chronic care model to improve first-line diabetes care: effects on assessment of chronic illness care and glycaemic control among people with diabetes enrolled to the First-Line Diabetes Care (FiLDCare) Project in the Northern Philippines.
    Ku GM; Kegels G
    Prim Health Care Res Dev; 2015 Sep; 16(5):481-91. PubMed ID: 25600305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disease-specific Pay-for-Performance Programs: Do the P4P Effects Differ Between Diabetic Patients With and Without Multiple Chronic Conditions?
    Huang YC; Lee MC; Chou YJ; Huang N
    Med Care; 2016 Nov; 54(11):977-983. PubMed ID: 27547944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost-effectiveness of diabetes pay-for-performance incentive designs.
    Hsieh HM; Tsai SL; Shin SJ; Mau LW; Chiu HC
    Med Care; 2015 Feb; 53(2):106-15. PubMed ID: 25397966
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the relationship between a chronic disease care management program and california pay-for-performance diabetes care cholesterol measures in one medical group.
    Cutler TW; Palmieri J; Khalsa M; Stebbins M
    J Manag Care Pharm; 2007 Sep; 13(7):578-88. PubMed ID: 17874864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Changes in Diabetes Pay-for-Performance Incentive Designs on Patient Risk Selection.
    Hsieh HM; Tsai SL; Mau LW; Chiu HC
    Health Serv Res; 2016 Apr; 51(2):667-86. PubMed ID: 26152649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Using financial incentives to improve the care of tuberculosis patients.
    Lee CY; Chi MJ; Yang SL; Lo HY; Cheng SH
    Am J Manag Care; 2015 Jan; 21(1):e35-42. PubMed ID: 25880266
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pay-for-performance program for diabetes care in Taiwan: a preliminary assessment.
    Lee TT; Cheng SH; Chen CC; Lai MS
    Am J Manag Care; 2010 Jan; 16(1):65-9. PubMed ID: 20148607
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetes care: Comparison of patients' and healthcare professionals' assessment using the PACIC instrument.
    Gijs E; Zuercher E; Henry V; Morin D; Bize R; Peytremann-Bridevaux I
    J Eval Clin Pract; 2017 Aug; 23(4):803-811. PubMed ID: 28251768
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Validity and reliability of the patient assessment on chronic illness care (PACIC) questionnaire: the Malay version.
    Abdul-Razak S; Ramli AS; Badlishah-Sham SF; Haniff J;
    BMC Fam Pract; 2018 Jul; 19(1):119. PubMed ID: 30025525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring and comparing the characteristics of nonlatent and latent composite scores: implications for pay-for-performance incentive design.
    Chen TT; Lai MS; Lin IC; Chung KP
    Med Decis Making; 2012; 32(1):132-44. PubMed ID: 21310853
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Does the pay-for-performance programme reduce the emergency department visits for hypoglycaemia in type 2 diabetic patients?
    Yu HC; Tsai WC; Kung PT
    Health Policy Plan; 2014 Sep; 29(6):732-41. PubMed ID: 23894069
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors related to continuing care and interruption of P4P program participation in patients with diabetes.
    Yen SM; Kung PT; Sheen YJ; Chiu LT; Xu XC; Tsai WC
    Am J Manag Care; 2016 Jan; 22(1):e18-30. PubMed ID: 26799201
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The association between participation in a pay-for-performance program and macrovascular complications in patients with type 2 diabetes in Taiwan: A nationwide population-based cohort study.
    Hsieh HM; Lin TH; Lee IC; Huang CJ; Shin SJ; Chiu HC
    Prev Med; 2016 Apr; 85():53-59. PubMed ID: 26740347
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seen through the patients' eyes: quality of chronic illness care.
    Desmedt M; Vertriest S; Petrovic M; Bergs J; Vrijhoef H; Dessers E; Hellings J; Vandijck D
    Fam Pract; 2018 Jul; 35(4):446-451. PubMed ID: 29236970
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is a diabetes pay-for-performance program cost-effective under the National Health Insurance in Taiwan?
    Tan EC; Pwu RF; Chen DR; Yang MC
    Qual Life Res; 2014 Mar; 23(2):687-96. PubMed ID: 23975377
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.